You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
VantaTM SCS is a high-performance recharge-free device optimised for longevity1, offering personalised programming, and unmatched MRI access*.Download Brochure
Vanta™ SCS recharge-free device.
Optimised for longevity1.
Vanta™ SCS is a high-performance recharge-free device offering optimised longevity
DTM™ SCS endurance therapy
DTM™ SCS endurance therapy is an energy modified differential target multiplexed therapy offering meaningful pain relief, satisfaction, and quality of life improvements.5
Clinical evidence for DTM™ SCS endurance therapy:
Meaningful pain relief
reduction in VAS for
overall pain from
baseline to 6-months
Quality of life improvements
had minimal to moderate disability at 3-months compared to only 16% at baseline
of patients were
very or somewhat
satisfied with therapy
Vanta™ has been enhanced for a better patient experience
|Width||1.1 cm (.44in)|
Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.
than PrimeAdvanced INS
The INS shall provide a minimum service life of 11 years from Beginning of Service to End of Service (EOS) for a bipolar single program with one bipolar electrode pair and stimulation settings of 1.6mA, 60µs, 130 Hz, and 550 ohms per electrode (resultant therapy power of 40µW). 977006 Vanta Implant Manual M998494A001 Rev C
Settings used from Abbott Proclaim™ clinician manual. Nominal settings 12 hours per day: 50-Hz frequency, 225-μs pulse width, and 5-mA amplitude at 500-ohms impedance. Compared to flagship model 3660.
Settings from Boston Scientific’s Alpha™ IFU. Programmed at 4.1mA, 280us, 40 Hz, 1 area, 730 Ohms, 2 contacts.
Provenzano, Amirdelfan, Grewal, et al. Modeling the impact of a differential target multiplexed derivative on rechargeable and recharge-free spinal cord stimulation systems using results from the Endurance Study. Poster presented at: International Neuromodulation Society (INS) World Congress; May 21-26, 2022; Barcelona, Spain.
Peacock, Provenzano, Fishman, et al. A prospective multi-center study of a differential target multiplexed™ stimulation derivative in therapy-naive patients. Poster presented at: International Neuromodulation Society (INS) World Congress; May 21-26, 2022; Barcelona, Spain.
Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531-537
Schultz D, Webster L, Kosek P, et al. Sensor-driven position-adaptive spinal cord stimulation for chronic pain. Pain Physician. 2012;15(1):1-12. 977006 Vanta Implant Manual M998494A001 Rev C
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.